BAY CITY CAPITAL LLC

Other

US·SEC (Form 4)

Xilio Therapeutics, Inc.Madrigal Pharmaceuticals, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by BAY CITY CAPITAL LLC. Insider active across 2 companies, notably Xilio Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. The latest transaction was filed on 3 December 2021 (J). Regulator: SEC (Form 4). The full history is free.

Declarations4 total

Executives●JMMadrigal Pharmaceuticals, INC.6SEC

B

BAY CITY CAPITAL LLC

0750,270 shares0

Common Stock

SEC:0000899243-21-047117·3 Dec 2021

SEC ↗

Executives●JMMadrigal Pharmaceuticals, INC.5SEC

B

BAY CITY CAPITAL LLC

0750,270 shares0